Related Experiment Videos

Therapeutic progress--review XXXI. Therapeutic progress in intensive care sedation and analgesia. Part II--Drug

J W Freeman¹, R B Hopkinson

¹Queen Elizabeth Hospital, Birmingham, U.K.

Journal of Clinical Pharmacy and Therapeutics

|February 1, 1988

Abstract:

In part I of this review the principles governing the uses of analgesics and sedatives in the ITU were considered. In part II we shall review the drugs available considering first, symptomatic therapy and secondly, regional analgesia.

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Knockdown of RON receptor kinase delays but does not prevent tumor progression while enhancing HGF/MET signaling in pancreatic cancer cell lines.

Oncogenesis·2013

Reolysin is a novel reovirus-based agent that induces endoplasmic reticular stress-mediated apoptosis in pancreatic cancer.

Cell death & disease·2013

PDLA/PLLA and PDLA/PCL nanofibers with a chitosan-based hydrogel in composite scaffolds for tissue engineered cartilage.

Journal of tissue engineering and regenerative medicine·2012

Coaxial electrospun poly(ε-caprolactone), multiwalled carbon nanotubes, and polyacrylic acid/polyvinyl alcohol scaffold for skeletal muscle tissue engineering.

Journal of biomedical materials research. Part A·2011

Characterization of electrospun poly(L-lactide) and gold nanoparticle composite scaffolds for skeletal muscle tissue engineering.

Journal of tissue engineering and regenerative medicine·2011

Fabrication and mechanical characterization of 3D electrospun scaffolds for tissue engineering.

Biomedical materials (Bristol, England)·2010

See all related articles